Cargando…
Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
BACKGROUND: Cardiovascular benefits by reversing environmental risks factors for essential hypertension (EH) and dyslipidemia could be weaken by high genetic risk. We investigated possible associations between ACE2 polymorphisms and dyslipidemia in patients with EH. METHODS: Four hundred and two hyp...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195726/ https://www.ncbi.nlm.nih.gov/pubmed/30342552 http://dx.doi.org/10.1186/s12944-018-0890-6 |
_version_ | 1783364443598487552 |
---|---|
author | Pan, Yizhi Wang, Tianyi Li, Yanfang Guan, Tianwang Lai, Yanxian Shen, Yan Zeyaweiding, Abudurexiti Maimaiti, Tutiguli Li, Fang Zhao, Haiyan Liu, Cheng |
author_facet | Pan, Yizhi Wang, Tianyi Li, Yanfang Guan, Tianwang Lai, Yanxian Shen, Yan Zeyaweiding, Abudurexiti Maimaiti, Tutiguli Li, Fang Zhao, Haiyan Liu, Cheng |
author_sort | Pan, Yizhi |
collection | PubMed |
description | BACKGROUND: Cardiovascular benefits by reversing environmental risks factors for essential hypertension (EH) and dyslipidemia could be weaken by high genetic risk. We investigated possible associations between ACE2 polymorphisms and dyslipidemia in patients with EH. METHODS: Four hundred and two hypertensive patients were enrolled in an EH group and 233 normotensive individuals were enrolled as control group from the Xinjiang region of China. Fourteen ACE2 polymorphisms were genotyped by Matrix-assisted laser desorption ionization time-of-flight mass spectrometry. RESULTS: Participants carrying T allele (TT + CT) of rs2074192 (P = 0.006), rs4646155 (P = 0.030) and rs4646188 (P < 0.001), C allele (CT + CT or CC + CG) of rs4240157 (P = 0.012), rs4830542 (P = 0.020) and rs879922 (P < 0.001) and TT genotype of rs2106809 (P = 0.012) were associated with EH. Meanwhile,ACE2 SNPs also exhibited association with dyslipidemia but exhibited obvious heterogeneity. rs1978124 (TT + CT, P = 0.009), rs2106809 (TT, P = 0.045), rs233575 (CC + CT, P = 0.018), rs4646188 (CC, P = 0.011) and rs879922 (CC + CG, P = 0.003) were association with increased LDL-C (≥1.8 mmol/L). rs2106809 (CC + CT, P < 0.001), rs2285666(TT + CT, P = 0.017), rs4646142(CC + CG, P = 0.044), rs4646155(TT + CT, P < 0.001) and rs4646188(TT + CT, P = 0.033) were association with decreased HDL-C (< 1.0 mmol/L). rs2074192 (TT + CT, P = 0.012), rs4240157 (CC + CT, P = 0.027), rs4646156 (AA+AT, P = 0.007), rs4646188 (TT + CT, P = 0.005), rs4830542 (CC + CT, P = 0.047) and rs879922 (CC + CG, P = 0.001) were association with increased TC (≥5.2 mmol/L). rs2106809 (P = 0.034) and rs4646188 (P = 0.013) were associated with hypertriglyceridemia. Further, ischemic stroke was more prevalent with rs4240157 (CC + CT, P = 0.043), rs4646188 (CC + CT, P = 0.013) and rs4830542 (CC + CT, P = 0.037). In addition, rs2048683 and rs6632677 were not association with EH, dyslipidemia and ischemic stroke. CONCLUSION: The ACE2 rs4646188 variant may be a potential and optimal genetic susceptibility marker for EH, dyslipidemia and its related ischemic stroke. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12944-018-0890-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6195726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61957262018-10-30 Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China Pan, Yizhi Wang, Tianyi Li, Yanfang Guan, Tianwang Lai, Yanxian Shen, Yan Zeyaweiding, Abudurexiti Maimaiti, Tutiguli Li, Fang Zhao, Haiyan Liu, Cheng Lipids Health Dis Research BACKGROUND: Cardiovascular benefits by reversing environmental risks factors for essential hypertension (EH) and dyslipidemia could be weaken by high genetic risk. We investigated possible associations between ACE2 polymorphisms and dyslipidemia in patients with EH. METHODS: Four hundred and two hypertensive patients were enrolled in an EH group and 233 normotensive individuals were enrolled as control group from the Xinjiang region of China. Fourteen ACE2 polymorphisms were genotyped by Matrix-assisted laser desorption ionization time-of-flight mass spectrometry. RESULTS: Participants carrying T allele (TT + CT) of rs2074192 (P = 0.006), rs4646155 (P = 0.030) and rs4646188 (P < 0.001), C allele (CT + CT or CC + CG) of rs4240157 (P = 0.012), rs4830542 (P = 0.020) and rs879922 (P < 0.001) and TT genotype of rs2106809 (P = 0.012) were associated with EH. Meanwhile,ACE2 SNPs also exhibited association with dyslipidemia but exhibited obvious heterogeneity. rs1978124 (TT + CT, P = 0.009), rs2106809 (TT, P = 0.045), rs233575 (CC + CT, P = 0.018), rs4646188 (CC, P = 0.011) and rs879922 (CC + CG, P = 0.003) were association with increased LDL-C (≥1.8 mmol/L). rs2106809 (CC + CT, P < 0.001), rs2285666(TT + CT, P = 0.017), rs4646142(CC + CG, P = 0.044), rs4646155(TT + CT, P < 0.001) and rs4646188(TT + CT, P = 0.033) were association with decreased HDL-C (< 1.0 mmol/L). rs2074192 (TT + CT, P = 0.012), rs4240157 (CC + CT, P = 0.027), rs4646156 (AA+AT, P = 0.007), rs4646188 (TT + CT, P = 0.005), rs4830542 (CC + CT, P = 0.047) and rs879922 (CC + CG, P = 0.001) were association with increased TC (≥5.2 mmol/L). rs2106809 (P = 0.034) and rs4646188 (P = 0.013) were associated with hypertriglyceridemia. Further, ischemic stroke was more prevalent with rs4240157 (CC + CT, P = 0.043), rs4646188 (CC + CT, P = 0.013) and rs4830542 (CC + CT, P = 0.037). In addition, rs2048683 and rs6632677 were not association with EH, dyslipidemia and ischemic stroke. CONCLUSION: The ACE2 rs4646188 variant may be a potential and optimal genetic susceptibility marker for EH, dyslipidemia and its related ischemic stroke. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12944-018-0890-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-20 /pmc/articles/PMC6195726/ /pubmed/30342552 http://dx.doi.org/10.1186/s12944-018-0890-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Pan, Yizhi Wang, Tianyi Li, Yanfang Guan, Tianwang Lai, Yanxian Shen, Yan Zeyaweiding, Abudurexiti Maimaiti, Tutiguli Li, Fang Zhao, Haiyan Liu, Cheng Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China |
title | Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China |
title_full | Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China |
title_fullStr | Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China |
title_full_unstemmed | Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China |
title_short | Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China |
title_sort | association of ace2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in xinjiang, china |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195726/ https://www.ncbi.nlm.nih.gov/pubmed/30342552 http://dx.doi.org/10.1186/s12944-018-0890-6 |
work_keys_str_mv | AT panyizhi associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina AT wangtianyi associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina AT liyanfang associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina AT guantianwang associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina AT laiyanxian associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina AT shenyan associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina AT zeyaweidingabudurexiti associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina AT maimaititutiguli associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina AT lifang associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina AT zhaohaiyan associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina AT liucheng associationoface2polymorphismswithsusceptibilitytoessentialhypertensionanddyslipidemiainxinjiangchina |